Research progress in OX40/OX40L in allergic diseases.

IF 7.2 2区医学 Q1 OTORHINOLARYNGOLOGY

International Forum of Allergy & Rhinology Pub Date : 2024-10-15 DOI:10.1002/alr.23469

Rongrong Song, Huanlei Zhang, Zhuoping Liang

引用次数: 0

Abstract

OX40/OX40L are costimulatory molecules in the tumor necrosis factor superfamily. Numerous studies have shown that OX40/OX40L are involved in immune regulation, especially in the proliferation and differentiation of T cells and the generation of memory T cells, which play important roles in allergic diseases. In recent years, the use of OX40/OX40L as therapeutic targets for treating T-cell-mediated diseases has attracted the interest of scholars. This paper reviews the role of OX40/OX40L in allergic diseases and the progress in clinical treatments targeting this signaling pathway.

查看原文本刊更多论文

OX40/OX40L 在过敏性疾病中的研究进展。

OX40/OX40L 是肿瘤坏死因子超家族中的激动分子。大量研究表明，OX40/OX40L 参与免疫调节，特别是参与 T 细胞的增殖和分化以及记忆 T 细胞的生成，在过敏性疾病中发挥重要作用。近年来，将 OX40/OX40L 作为治疗 T 细胞介导疾病的靶点引起了学者们的兴趣。本文回顾了OX40/OX40L在过敏性疾病中的作用以及针对这一信号通路的临床治疗进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Forum of Allergy & Rhinology OTORHINOLARYNGOLOGY-

CiteScore

11.70

自引率

10.90%

发文量

185

审稿时长

6-12 weeks

期刊介绍： International Forum of Allergy & Rhinologyis a peer-reviewed scientific journal, and the Official Journal of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. International Forum of Allergy Rhinology provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions. The application of current research to the management of otolaryngic allergy, rhinologic, and skull base diseases and the need for further investigation will be highlighted.